VGXI, a GeneOne company, is a global leader in contract manufacturing of cGMP nucleic acid-based products including DNA plasmids and mRNA. High purity and high concentration production of nucleic acid-based drugs by VGXI, Inc. is made possible through its patented AIRMIX® technology.

DNA plasmids are used as a raw material in the production of the gene therapy drugs like CAR-T. DNA plasmids are also used as the templates for mRNA-based gene therapy products and/ or vaccines.

Demand for high quality DNA plasmids is expected to continue to increase.